Skip to main content

Table 2 FDG SULmax and FLT SULmax values at all time points for each patient

From: A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB–IIIA resectable NSCLC

Patient number

Baseline

Post-cycle 1

Post-cycle 2

FDG

FLT

CT

FDG

FLT

CT (%)

FDG

FLT

CT (%)

1

9.3

3.4

6.5

8.8

6.8

3.1

4.1

2.2

−7.7

2*

12.7

5.2

7.4

3.4

1.7

−45.9

1.5

1.0

−56.8

3

3.2

2.3

2.4

4.0

1.0

4.2

3.3

1.1

−8.3

4

8.3

4.5

8.6

6.7

2.9

44.2

14.0

−16.3

5

14.0

4.6

5.4

14.6

4.4

31.5

7.4

3.9

−29.6

6*

10.9

4.9

5.9

8.9

4.2

−25.4

8.6

4.4

−52.5

7

5.5

2.7

2.1

7.7

2.9

0.0

5.4

2.5

−14.3

8

7.1

4.2

11.5

6.9

4.6

−23.5

6.7

5.3

−27.8

9*

8.4

2.1

8.4

4.8

1.8

−21.4

3.9

1.4

−44.0

  1. Post-cycle 1 and post-cycle 2 CT values are shown as percentage changes from baseline. Responders are denoted by an asterisk after the patient number